Renal cell carcinoma: prognostic factors and patient selection
AS Belldegrun - european urology supplements, 2007 - Elsevier
Renal cell carcinoma (RCC) accounts for 2% of all new cancer cases worldwide. Staging
systems for RCC are a valuable tool for guiding patient selection for the various treatment
regimens and clinical trials. Integration of pathologic tumour stage with histologic and
clinical features has led to the development of a number of comprehensive prognostication
systems to predict patient outcomes. More recent work has highlighted the additional
prognostic value of a range of molecular markers, which may correlate disease status with …
systems for RCC are a valuable tool for guiding patient selection for the various treatment
regimens and clinical trials. Integration of pathologic tumour stage with histologic and
clinical features has led to the development of a number of comprehensive prognostication
systems to predict patient outcomes. More recent work has highlighted the additional
prognostic value of a range of molecular markers, which may correlate disease status with …